These results support the previously proposed hypothesis that MEN2A RET pathogenic variants can determine the age of onset of MTC, but that MTC is an equally aggressive tumour in both moderate- and high-risk groups after its initial onset. This evidence concerns the gene RET and medullary thyroid gland carcinoma.